BACKGROUND: Hepatic encephalopathy is considered to be mainly caused by increased ammonia metabolism of the brain. If this hypothesis is true, cerebral glucose utilisation, which is considered to represent brain function, should be closely related to cerebral ammonia metabolism. The aim of the present study was to analyse whether cerebral ammonia and glucose metabolism in cirrhotic patients with early grades of hepatic encephalopathy are as closely related as could be expected from current hypotheses on hepatic encephalopathy. METHODS: (13)N-ammonia and (18)F-fluorodesoxyglucose positron emission tomography, magnetic resonance imaging and magnetic resonance spectroscopy (MRS) were performed in 21 cirrhotic patients with grade 0-1 hepatic encephalopathy. Quantitative values of cerebral ammonia uptake and retention rate and glucose utilisation were derived for several regions of interest and were correlated with the MRS data of the basal ganglia, white matter and frontal cortex. RESULTS: A significant correlation between plasma ammonia levels and cerebral ammonia metabolism, respectively, and MRS alterations could be shown only for white matter. In contrast, MRS alterations in all three regions studied were significantly correlated with the glucose utilisation of several brain regions. Cerebral ammonia and glucose metabolism were not correlated. CONCLUSION: Increase of cerebral ammonia metabolism is an important but not exclusive causal factor for the development of hepatic encephalopathy.
BACKGROUND:Hepatic encephalopathy is considered to be mainly caused by increased ammonia metabolism of the brain. If this hypothesis is true, cerebral glucose utilisation, which is considered to represent brain function, should be closely related to cerebral ammonia metabolism. The aim of the present study was to analyse whether cerebral ammonia and glucose metabolism in cirrhoticpatients with early grades of hepatic encephalopathy are as closely related as could be expected from current hypotheses on hepatic encephalopathy. METHODS: (13)N-ammonia and (18)F-fluorodesoxyglucose positron emission tomography, magnetic resonance imaging and magnetic resonance spectroscopy (MRS) were performed in 21 cirrhotic patients with grade 0-1 hepatic encephalopathy. Quantitative values of cerebral ammonia uptake and retention rate and glucose utilisation were derived for several regions of interest and were correlated with the MRS data of the basal ganglia, white matter and frontal cortex. RESULTS: A significant correlation between plasma ammonia levels and cerebral ammonia metabolism, respectively, and MRS alterations could be shown only for white matter. In contrast, MRS alterations in all three regions studied were significantly correlated with the glucose utilisation of several brain regions. Cerebral ammonia and glucose metabolism were not correlated. CONCLUSION: Increase of cerebral ammonia metabolism is an important but not exclusive causal factor for the development of hepatic encephalopathy.
Authors: L Spahr; F Vingerhoets; F Lazeyras; J Delavelle; R DuPasquier; E Giostra; G Mentha; F Terrier; A Hadengue Journal: Gastroenterology Date: 2000-09 Impact factor: 22.682
Authors: Björn Ahl; Karin Weissenborn; Jörg van den Hoff; Daniela Fischer-Wasels; Herbert Köstler; Hartmut Hecker; Wolfgang Burchert Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: Sherzad Balata; Steven W M Olde Damink; Karen Ferguson; Ian Marshall; Peter C Hayes; Nicolaas E p Deutz; Roger Williams; Joanna Wardlaw; Rajiv Jalan Journal: Hepatology Date: 2003-04 Impact factor: 17.425
Authors: Janus P Ong; Anjana Aggarwal; Derk Krieger; Kirk A Easley; Matthew T Karafa; Frederick Van Lente; Alejandro C Arroliga; Kevin D Mullen Journal: Am J Med Date: 2003-02-15 Impact factor: 4.965
Authors: Konstantinos John Dabos; John Andrew Parkinson; Ian Howard Sadler; John Nicholas Plevris; Peter Clive Hayes Journal: World J Hepatol Date: 2015-06-28
Authors: Manoj K Sarma; Amir Huda; Rajakumar Nagarajan; Charles H Hinkin; Neil Wilson; Rakesh K Gupta; Enrique Frias-Martinez; James Sayre; Barry Guze; Steven-Huy Han; M Albert Thomas Journal: Metab Brain Dis Date: 2011-06-23 Impact factor: 3.584